Business Context and Reporting Period
Company: Bristol-Myers Squibb Company (BMY)
Filing Type: Form 8-K (Current Report)
Date of Report: April 27, 2023
Reporting Period: First Quarter of 2023
This filing serves as a notification that the Company issued an Earnings Press Release and posted a presentation regarding its financial results for the first quarter of 2023. The detailed financial data is contained within the attached exhibits (Exhibit 99.1 and 99.2) and is incorporated by reference.
Key Financial Metrics
The provided text is a procedural filing and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the Earnings Press Release (Exhibit 99.1) and the Bristol Myers Presentation (Exhibit 99.2).
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the body text. It directs investors to the Earnings Press Release for the announcement of financial results and any associated changes.
Guidance, Outlook, and Management Commentary
- Disclosure Method: Management commentary and financial initiatives were presented via a conference call and webcast on April 27, 2023, at 8:00 a.m. Eastern time.
- Non-GAAP Measures: The Earnings Press Release and Presentation include references to non-GAAP financial information. Reconciliations to GAAP measures are available in Exhibit 99.1.
- Regulation FD: The presentation materials are furnished under Item 7.01 for Regulation FD disclosure purposes but are not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for specific Q1 2023 revenue, net income, and earnings per share figures.
- Examine Exhibit 99.2 (Presentation Materials) for management's outlook, strategic initiatives, and non-GAAP reconciliations.
- Verify the reconciliation between non-GAAP and GAAP financial measures as required by the filing.
- Confirm the availability of the presentation on the company website, noting the Company reserves the right to discontinue access at any time.